VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BCAX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BCAXBicara Therapeutics Inc. Common Stock
$8.65$568M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBCAXQuarterly Balance Sheet

Bicara Therapeutics Inc. Common Stock (BCAX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Bicara Therapeutics Inc. Common Stock (BCAX) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

BCAX Balance Sheet

Quarterly statement

BCAX Balance Sheet

Bicara Therapeutics Inc. Common Stock (BCAX) balance sheet — 4-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q1'23
Total Current Assets503.82M544.91M422.05M297.37M444.39M470.75M502.53M521.51M206.08M206.08M231.07M0
Cash & Short-Term Investments497.26M539.75M414.8M290.17M436.61M462.06M489.71M520.76M203.85M203.85M230.44M4.16M
Cash Only96.6M323.46M96.69M171.67M436.61M462.06M489.71M520.76M203.85M203.85M230.44M0
Short-Term Investments400.66M216.29M318.12M118.49M00000000
Accounts Receivable000000000000
Days Sales Outstanding------------
Inventory000000000000
Days Inventory Outstanding------------
Other Current Assets6.56M5.16M7.25M7.21M7.79M8.69M12.82M756K2.22M0100K-4.16M
Total Non-Current Assets8.42M8.68M8.94M127.32M9.2M7.32M66.66M2.66M2.71M2.71M2.91M0
Property, Plant & Equipment1.51M1.77M2.03M2.1M2.35M688K845K544K619K619K815K0
Fixed Asset Turnover------------
Goodwill000000000000
Intangible Assets000000000000
Long-Term Investments000117.42M00000000
Other Non-Current Assets6.91M6.91M6.91M7.79M6.84M6.63M6.62M2.12M2.09M2.09M2.09M0
Total Assets512.24M553.6M430.99M424.69M453.59M478.08M569.2M524.17M208.78M208.78M233.98M0
Asset Turnover------------
Asset Growth %12.93%15.8%-24.28%-18.98%117.25%128.98%143.26%-----
Total Current Liabilities43.48M39.34M28.95M21.03M17.23M19.12M17.99M14.48M16.07M16.07M15.09M0
Accounts Payable8.46M7.44M7.79M3.66M2.91M2.74M4.51M1.96M4.68M4.68M3.19M0
Days Payables Outstanding------------
Short-Term Debt1.16M00000607K00000
Deferred Revenue (Current)000000000000
Other Current Liabilities33.85M1.91M5.04M3.99M2.17M1.68M9.79M1.81M1.12M000
Current Ratio11.59x13.85x14.58x14.14x25.80x24.62x27.93x36.01x12.83x12.83x15.32x-
Quick Ratio11.59x13.85x14.58x14.14x25.80x24.62x27.93x36.01x12.83x12.83x15.32x-
Cash Conversion Cycle------------
Total Non-Current Liabilities0301K593K880K1.16M059.33M137K367.49M217K389K17.28M
Long-Term Debt0301K0880K00000000
Capital Lease Obligations00593K01.16M0131K137K217K217K372K0
Deferred Tax Liabilities00000059.2M00000
Other Non-Current Liabilities00000000367.28M-218.51M17K17.28M
Total Liabilities43.48M39.64M29.54M21.91M18.39M19.12M77.32M14.62M383.56M16.28M15.47M17.28M
Total Debt1.16M1.44M1.71M1.98M2.24M591K738K445K517K517K657K0
Net Debt-95.44M-322.02M-94.97M-169.7M-434.37M-461.47M-488.97M-520.31M-203.34M-203.34M-229.78M0
Debt / Equity0.00x0.00x0.00x0.00x0.01x0.00x0.00x0.00x-0.00x0.00x-
Debt / EBITDA------------
Net Debt / EBITDA------------
Interest Coverage------------
Total Equity468.77M513.96M401.45M402.78M435.2M458.96M491.88M509.56M-174.78M192.5M218.51M-17.28M
Equity Growth %7.71%11.98%-18.38%-20.95%349%138.42%125.11%--1214.14%--
Book Value per Share6.908.467.287.387.988.439.049.37-3.233.554.12-0.32
Total Shareholders' Equity468.77M513.96M401.45M402.78M435.2M458.96M491.88M509.56M-174.78M192.5M218.51M-17.28M
Common Stock8K8K7K7K7K7K7K7K2K2K2K0
Retained Earnings-470.61M-415.18M-358.97M-321.58M-285.25M-257.86M-221.02M-200.06M-182.58M-182.58M-153.02M0
Treasury Stock000000000000
Accumulated OCI-567K-243K243K-136K0000000-98.8M
Minority Interest000000000000